drugset / Trial / NCT00004022
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Treatment
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of biological therapy following surgery in treating patients who have stage III or stage IV melanoma.
Timeline
- Start
- 1997-06
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aldesleukin | Protein / enzyme biologic | — | Intravenous |
| Subject | autologous tumor cell vaccine | Vaccine | — | — |
| Subject | therapeutic autologous lymphocytes | Cell therapy | — | Intravenous |
| Background | muromonab-CD3 | Monoclonal antibody | — | — |